• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮平治疗患者的心血管疾病:证据、机制与管理。

Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

机构信息

Department of Epidemiology and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.

出版信息

CNS Drugs. 2017 Sep;31(9):777-795. doi: 10.1007/s40263-017-0461-9.

DOI:10.1007/s40263-017-0461-9
PMID:28808933
Abstract

Myocarditis occurs in about 3% of those initiated on clozapine but monitoring reduces the risk of serious outcome. Cardiomyopathy may develop after myocarditis, or from prolonged tachycardia. Monitoring using echocardiography is not deemed cost effective. Tachycardia, orthostatic hypotension and reduced heart rate variability are a group of clozapine-related adverse effects associated with autonomic dysfunction and may have serious consequences in the long term. Elevated heart rate and poor heart rate variability can be treated with a β-blocker or a non-dihydropyridine calcium channel blocker, while orthostatic hypotension can be alleviated by increased fluid intake and abdominal binding, but may require pharmacological intervention. Adequate correction for heart rate may show that clozapine does not prolong the QT interval. Other cardiovascular effects, pulmonary embolism, metabolic syndrome, sudden cardiac death and particularly the excessive mortality from cardiovascular disease events may be more strongly associated with the combination of mental illness, lifestyle factors and poor treatment of cardiovascular disease and its risk factors than with clozapine treatment. In view of the efficacy of clozapine and the evidence of reduced mortality relative to other antipsychotics, clozapine should be prescribed when indicated and recipients should be enrolled in lifestyle programmes to increase exercise and improve diet, and referred for diagnosis and treatment of cardiovascular disease and its risk factors.

摘要

心肌炎在接受氯氮平治疗的患者中约占 3%,但监测可降低严重后果的风险。心肌炎后或长期心动过速可能导致心肌病。使用超声心动图监测被认为不具有成本效益。心动过速、体位性低血压和心率变异性降低是一组与自主神经功能障碍相关的氯氮平相关不良影响,长期来看可能会产生严重后果。升高的心率和较差的心率变异性可以用β受体阻滞剂或非二氢吡啶类钙通道阻滞剂治疗,而体位性低血压可以通过增加液体摄入和腹部包扎来缓解,但可能需要药物干预。适当纠正心率可能表明氯氮平不会延长 QT 间期。其他心血管效应、肺栓塞、代谢综合征、心源性猝死,特别是心血管疾病事件导致的死亡率过高,可能与精神疾病、生活方式因素以及心血管疾病及其危险因素的治疗不佳的关联比与氯氮平治疗的关联更为密切。鉴于氯氮平的疗效和与其他抗精神病药物相比死亡率降低的证据,当指征明确时应开氯氮平处方,应将患者纳入生活方式方案以增加运动和改善饮食,并转介进行心血管疾病及其危险因素的诊断和治疗。

相似文献

1
Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.氯氮平治疗患者的心血管疾病:证据、机制与管理。
CNS Drugs. 2017 Sep;31(9):777-795. doi: 10.1007/s40263-017-0461-9.
2
Adverse cardiac effects associated with clozapine.与氯氮平相关的心脏不良反应。
J Clin Psychopharmacol. 2005 Feb;25(1):32-41. doi: 10.1097/01.jcp.0000150217.51433.9f.
3
[Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].[心肌炎与心肌病:氯氮平治疗引发的被低估的并发症]
Tijdschr Psychiatr. 2010;52(4):223-33.
4
Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.澳大利亚某地区心理健康服务机构中氯氮平所致心肌炎和心肌病的发病率及危险因素
Australas Psychiatry. 2016 Apr;24(2):176-80. doi: 10.1177/1039856215604480. Epub 2015 Sep 23.
5
[Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].[关于“心肌炎和心肌病:氯氮平治疗引发的并发症被低估”的反应]
Tijdschr Psychiatr. 2011;53(3):193-4.
6
[Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].[关于“氯氮平治疗导致的心肌炎和心肌病——被低估的并发症”的反应]
Tijdschr Psychiatr. 2010;52(10):727-8; author reply 728-9.
7
Clozapine and sudden death.氯氮平与猝死
Lancet. 2000 Mar 4;355(9206):841; author reply 843. doi: 10.1016/s0140-6736(00)00035-0.
8
Cardiovascular disease in patients with schizophrenia.精神分裂症患者的心血管疾病。
Med J Aust. 2017 Feb 6;206(2):91-95. doi: 10.5694/mja16.00650.
9
Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.澳大利亚一家大都市精神病服务机构中与氯氮平相关的心肌炎和心肌病
Aust N Z J Psychiatry. 2004 Nov-Dec;38(11-12):915-22. doi: 10.1080/j.1440-1614.2004.01481.x.
10
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.氯氮平诱导的心肌病和心肌炎监测:系统评价。
Schizophr Res. 2018 Sep;199:17-30. doi: 10.1016/j.schres.2018.03.006. Epub 2018 Mar 13.

引用本文的文献

1
A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis.氯氮平所致心肌炎的临床进展与挑战综述
Neuropsychiatr Dis Treat. 2025 Mar 7;21:525-538. doi: 10.2147/NDT.S502312. eCollection 2025.
2
Clozapine is a functional antagonist at cardiac human H-histamine receptors.氯氮平是心脏人类H组胺受体的功能性拮抗剂。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 11. doi: 10.1007/s00210-024-03683-7.
3
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.评估氯氮平所致不良反应的监测指南:一项系统评价

本文引用的文献

1
Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: a meta-analysis.静息心率与冠状动脉疾病、中风、猝死及非心血管疾病之间的关联:一项荟萃分析。
CMAJ. 2016 Oct 18;188(15):E384-E392. doi: 10.1503/cmaj.160050. Epub 2016 Aug 22.
2
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.澳大利亚和新西兰皇家精神科医学院精神分裂症及相关障碍管理临床实践指南。
Aust N Z J Psychiatry. 2016 May;50(5):410-72. doi: 10.1177/0004867416641195.
3
Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking.
CNS Drugs. 2024 Feb;38(2):105-123. doi: 10.1007/s40263-023-01054-z. Epub 2024 Jan 18.
4
[Safety aspects during treatment with clozapine: : Adverse effects, titration, and therapeutic drug monitoring - a narrative review].[氯氮平治疗期间的安全问题:不良反应、滴定和治疗药物监测——一篇叙述性综述]
Neuropsychiatr. 2023 Sep;37(3):122-129. doi: 10.1007/s40211-023-00474-z. Epub 2023 Jun 22.
5
Clozapine-Related Thromboembolic Events.氯氮平相关的血栓栓塞事件
Cureus. 2021 Aug 4;13(8):e16883. doi: 10.7759/cureus.16883. eCollection 2021 Aug.
6
Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma.锂与非典型抗精神病药物:青光眼可能的WNT/β信号通路靶点
Biomedicines. 2021 Apr 26;9(5):473. doi: 10.3390/biomedicines9050473.
7
A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43.关于氯氮平通过激活连接蛋白 43在临床疗效和不良反应之间具有相同的作用机制的工作假说。
Int J Mol Sci. 2020 Sep 24;21(19):7019. doi: 10.3390/ijms21197019.
8
The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services.使用氯氮平患者的身体健康及副作用监测:来自英国精神卫生服务机构临床审计的数据
Ther Adv Psychopharmacol. 2020 Aug 6;10:2045125320937908. doi: 10.1177/2045125320937908. eCollection 2020.
9
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.基于药物不良反应、药代动力学和临床精神药理学的氯氮平合理应用。
Psychother Psychosom. 2020;89(4):200-214. doi: 10.1159/000507638. Epub 2020 Apr 14.
10
Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013.抗精神病药治疗期间的心血管不良反应:1993 年至 2013 年期间 AMSP 药物监测计划的结果。
Int J Neuropsychopharmacol. 2020 Feb 1;23(2):67-75. doi: 10.1093/ijnp/pyz046.
预测接受氯氮平治疗患者的体重增加:性别、体重指数和吸烟的作用。
J Clin Psychopharmacol. 2016 Apr;36(2):120-4. doi: 10.1097/JCP.0000000000000476.
4
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.抗精神病药治疗难治性精神分裂症的疗效、可接受性和耐受性:网络荟萃分析。
JAMA Psychiatry. 2016 Mar;73(3):199-210. doi: 10.1001/jamapsychiatry.2015.2955.
5
Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.氯氮平反应及所致体重增加的药物遗传学:一项全面综述与荟萃分析
Eur Neuropsychopharmacol. 2016 Feb;26(2):163-185. doi: 10.1016/j.euroneuro.2015.12.035. Epub 2015 Dec 29.
6
Resting vagal activity in schizophrenia: meta-analysis of heart rate variability as a potential endophenotype.精神分裂症的静息迷走神经活动:心率变异性作为一种潜在的内表型的荟萃分析。
Br J Psychiatry. 2016 Jan;208(1):9-16. doi: 10.1192/bjp.bp.114.160762.
7
Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.氯氮平与标准抗精神病药物治疗成人精神分裂症的疗效比较。
Am J Psychiatry. 2016 Feb 1;173(2):166-73. doi: 10.1176/appi.ajp.2015.15030332. Epub 2015 Nov 6.
8
Premature Mortality Among Adults With Schizophrenia in the United States.美国精神分裂症成年患者的过早死亡率。
JAMA Psychiatry. 2015 Dec;72(12):1172-81. doi: 10.1001/jamapsychiatry.2015.1737.
9
Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.澳大利亚某地区心理健康服务机构中氯氮平所致心肌炎和心肌病的发病率及危险因素
Australas Psychiatry. 2016 Apr;24(2):176-80. doi: 10.1177/1039856215604480. Epub 2015 Sep 23.
10
C-reactive protein: an early critical sign of clozapine-related myocarditis.C反应蛋白:氯氮平相关性心肌炎的早期关键体征
Australas Psychiatry. 2016 Apr;24(2):181-4. doi: 10.1177/1039856215604482. Epub 2015 Sep 23.